In this week’s View, Dr. Eagle looks at a study comparing three diuretic regimens in ambulatory congested heart failure (HF) patients (DEA-HF). He then explores a randomized trial that investigates the effects of implantable cardioverter-defibrillator (ICD) leads on the tricuspid valve and right ventricle. Finally, Dr. Eagle discusses the effects of rapid up-titration of neurohormonal blockade in patients with acute decompensated HF.    Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the ARISE-HF trial that examined racial differences in diabetic cardiomyopathy. He then explores established and emerging implications of treatment of genetic hypertrophic cardiomyopathy (HCM). Finally, Dr. Eagle discusses the use of GLP-1 agonists, including semaglutide vs. tirzepatide for weight loss in adults with overweight or obesity.   Subscribe to Eagle’s Eye View    

In this week’s View, Dr. Eagle discusses a state-of-the-art review on iron repletion for patients with heart failure and iron deficiency. He then explores the diagnosis and management of ventricular septal defect complicating acute myocardial infarction. Finally, Dr. Eagle discusses practical guidance for hemodynamic assessment by right heart catheterization in management of heart failure.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the clinical impact of early rhythm control and healthy lifestyles in patients with atrial fibrillation, then explores the use of low-dose aspirin in the prevention of atherosclerotic cardiovascular disease. Finally, Dr. Eagle discusses the association of autoimmune diseases with coronary atherosclerosis and ischemic events.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at office measurement vs. ambulatory blood pressure monitoring and its associations with mortality in patients with or without diabetes. Dr. Eagle then reviews two related articles: a report in JACC on Artificial Intelligence and cardiovascular care, and a recent article from The Lancet on inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease in which AI played an important role.  Subscribe to Eagle’s Eye...

In this week’s View, Dr. Eagle looks at secular trends of incidence and outcomes in severe aortic stenosis. He then examines titration of medications after acute heart failure. Finally, Dr. Eagle shares some thoughts on an analysis from the PARTNER2-S3 registry on the predictors and five-year clinical outcomes of pacemakers after TAVR.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at excess apolipoprotein-B and cardiovascular risk, then examines a recent meta-analysis on treating pulmonary arterial hypertension. Finally, Dr. Eagle shares some thoughts on a SMART-C collaborative meta-analysis of sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting. He then examines a meta-analysis of invasive vs. conservative management of non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting. Finally, Dr. Eagle shares some thoughts on JACC’s recent State of the Art Review of arrhythmia-induced cardiomyopathy.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the diagnostic value of aortic valve calcification levels in the assessment of low-gradient aortic stenosis.    He then examines the prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction.    Finally, Dr. Eagle shares some thoughts on clinical outcomes associated with various microvascular injury patterns identified by cardiac MRI after STEMI.  Subscribe to...

In this week’s View, Dr. Eagle looks at transcatheter-based intervention for tetraology of Fallot. He then examines how a small left ventricle in patients with atrial fibrillation is associated with increased cardiovascular risk. Finally, Dr. Eagle shares some thoughts on an aspirin-free strategy for immediate treatment following complex percutaneous coronary intervention.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the recently released guidelines for lower extremity peripheral arterial disease (PAD). He then examines a national community-based cohort study on contemporary decongestion strategies in patients hospitalized for heart failure. Finally, Dr. Eagle shares some thoughts on the implications of discordance among ApoB, non–high-density lipoprotein cholesterol and triglycerides for cardiovascular prevention.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the new AHA/ACC Hypertrophic Cardiomyopathy Guideline, then examines a randomized clinical trial that studied smoking cessation after initial treatment failure with varenicline or nicotine. Finally, Dr. Eagle shares some thoughts on a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging, and the European Heart Rhythm Association of the ESC on embolic strokes of an undetermined source.  ...

In this week’s View, Dr. Eagle looks at the durability of pulmonary vein isolation using pulsed-field ablation, then examines genetic penetrance of dilated cardiomyopathy in genotype-positive relatives. Finally, Dr. Eagle shares some thoughts on reinterventions after CoreValve/Evolut TAVR or SAVR for treatment of severe aortic stenosis.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at a scientific statement from the American Heart Association on the diagnosis and management of cardiac sarcoidosis. He then examines the temporal trends and clinical implications of ischemic stroke in women with atrial fibrillation. Finally, Dr. Eagle shares some thoughts on transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR).  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at a systematic review and meta-analysis of antibiotic prophylaxis and infective endocarditis incidence following invasive dental procedures. He then examines the issue of serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or rivaroxaban. Finally, Dr. Eagle shares some thoughts on low-dose colchicine for secondary prevention in atherosclerosis.  Subscribe to Eagle’s Eye View    

In this special edition of Eagle’s Eye View, Dr. Eagle introduces you to ACC24 featuring valuable insights into practice-changing updates in care. The topics include late-breaking clinical trials and science focusing on new drugs and device therapies.   Tune into ACC.org’s coverage of ACC.24 to hear from the top experts as they debate, discuss the results of the trials, share visual abstracts and find out how it all fits into your practice. The transformation of care begins at ACC.24.   ...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from Day 3, Monday, April 7 at the American College of Cardiology Scientific Sessions 2024 in Atlanta. Trials on Monday include TARGET BP I (0:39), DEDICATE-DZHK6 (3:07), and FULL REVASC (6:31). For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ACC24.  Subscribe to Eagle’s Eye View  

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from Day 2, Sunday, April 6 at the American College of Cardiology Scientific Sessions 2024 in Atlanta. Trials on Sunday include REDUCE-AMI (0:35), DanGer-Shock (3:28), ULTIMATE-DAPT (6:17) and TACT2 (10:04). For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ACC24.  Subscribe to...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from Day 1, Saturday, April 5 at the American College of Cardiology Scientific Sessions 2024 in Atlanta. Trials on Saturday include AEGIS II (0:45), VICTORION-INITIATE (2:36), RELIEVE-HF (5:27) and Step-HFpEF Dm (8:42). For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ACC24.  ...

In this week’s View, Dr. Eagle looks at the timing of complete multivessel revascularization in patients presenting with non-ST-Elevation Acute Coronary Syndrome, then examines the accuracy of wearable heart rate monitors during exercise in sinus rhythm and atrial fibrillation. Finally, Dr. Eagle shares some thoughts on a multinational observation study on sports-related sudden cardiac death.  Subscribe to Eagle’s Eye View    

In this special edition of Eagle’s Eye View, Dr. Eagle highlights the latest science and innovation being presented at ACC.24 in Atlanta, Georgia from April 6-8. He gives us valuable insights into practice-changing updates in care. The topics include late-breaking clinical trials and science focusing on new drugs and device therapies.  Tune into ACC.org’s coverage of ACC.24 to hear from the top experts as they debate, discuss the results of the trials, share visual abstracts and find out...

In this week’s View, Dr. Eagle looks at sacubitril/valsartan in patients hospitalized with decompensated heart failure, then examines the prevalence and outcomes of patients with discordant high gradient aortic stenosis. Finally, Dr. Eagle shares some thoughts on current concepts regarding transcatheter treatment of tricuspid valve regurgitation.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI. He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Finally, Dr. Eagle discusses four studies comparing percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main disease with or without diabetes.  Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle covers various blood pressure parameters and their predictability for peripheral arterial disease (PAD) and complications, then explores the five-year outcomes of leadless pacemakers. Finally, Dr. Eagle discusses the role of palliative care in the spectrum of treating patients with heart failure.  Subscribe to Eagle’s Eye View